PGAM
IBBQ icon

Princeton Global Asset Management’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Princeton Global Asset Management’s Portfolio IBBQ Stock Details IBBQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.6K Buy
601
+401
+201% +$11.9K ﹤0.01% 485
2026
Q1 		$5.8K Hold
200
– – ﹤0.01% 666
2025
Q4 		$5.68K Hold
200
– – ﹤0.01% 661
2025
Q3 		$4.86K Buy
+200
New +$4.6K ﹤0.01% 632

Other funds holding IBBQ

WG
WMS Group Folsom, Louisiana $77.5M AUM
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CFA
Churchill Financial Advisors Louisville, Kentucky $519M AUM
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
RWML
RAFFA WEALTH MANAGEMENT, LLC Washington, District of Columbia $793M AUM 13.11% 1-Year Est. Return
IP
Ignite Planners San Clemente, California $729M AUM 24.39% 1-Year Est. Return
BCG
Breakwater Capital Group Paramus, New Jersey $833M AUM 22.71% 1-Year Est. Return
LW
Lauer Wealth Valparaiso, Indiana $167M AUM 23.59% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
PTC
Private Trust Company Cleveland, Ohio $1.25B AUM 29.12% 1-Year Est. Return

Princeton Global Asset Management's IBBQ Position: Q2 2026 in Review

Princeton Global Asset Management increased its Invesco NASDAQ Biotechnology ETF (IBBQ) stake by 201% in Q2 2026, buying an estimated $11.9K and bringing the position to 601 shares worth $19.6K. The position accounts for ﹤0.01% of the portfolio, ranked #485.

Princeton Global Asset Management first reported a position in IBBQ in Q3 2025 and has held it in 4 quarters since. 14 funds tracked by Wall St. Rank hold IBBQ as of Q2 2026.

  • Princeton Global Asset Management held 601 shares of Invesco NASDAQ Biotechnology ETF worth $19.6K as of Q2 2026.
  • Princeton Global Asset Management bought 401 Invesco NASDAQ Biotechnology ETF shares in Q2 2026, an estimated $11.9K.
  • Invesco NASDAQ Biotechnology ETF made up ﹤0.01% of Princeton Global Asset Management's portfolio in Q2 2026, its #485 holding.
  • Princeton Global Asset Management first reported a position in Invesco NASDAQ Biotechnology ETF in Q3 2025 and has held it in 4 quarters since.
  • 14 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q2 2026.

Based on Princeton Global Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.